Detalhe da pesquisa
1.
PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371.
Blood
; 141(3): 244-259, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206490
2.
Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity.
Molecules
; 28(19)2023 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37836790
3.
Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T-Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy.
Angew Chem Int Ed Engl
; 62(22): e202303818, 2023 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36973833
4.
Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation.
ChemMedChem
; 19(7): e202300669, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38233347
5.
Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models.
Cancer Res Commun
; 4(1): 5-17, 2024 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38047587
6.
Development of Novel Phosphonodifluoromethyl-Containing Phosphotyrosine Mimetics and a First-In-Class, Potent, Selective, and Bioavailable Inhibitor of Human CDC14 Phosphatases.
J Med Chem
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768084
7.
PRL2 Phosphatase Promotes Oncogenic KIT Signaling in Leukemia Cells through Modulating CBL Phosphorylation.
Mol Cancer Res
; 22(1): 94-103, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37756563
8.
Discovery of a selective TC-PTP degrader for cancer immunotherapy.
Chem Sci
; 14(44): 12606-12614, 2023 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38020389
9.
Driving axon regeneration by orchestrating neuronal and non-neuronal innate immune responses via the IFNγ-cGAS-STING axis.
Neuron
; 111(2): 236-255.e7, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370710
10.
Tumor Cell-Autonomous SHP2 Contributes to Immune Suppression in Metastatic Breast Cancer.
Cancer Res Commun
; 2(10): 1104-1118, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36969745
11.
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors.
Nat Commun
; 12(1): 6274, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34725361
12.
SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer.
Oncogene
; 39(49): 7166-7180, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33033382
13.
Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation.
Nat Commun
; 10(1): 224, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30644389
14.
Copper-catalyzed aerobic dehydrogenative cyclization of N-methyl-N-phenylhydrazones: synthesis of cinnolines.
Angew Chem Int Ed Engl
; 51(33): 8318-21, 2012 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22782712
15.
Copper-promoted site-selective carbonylation of sp3 and sp2 C-H bonds with nitromethane.
Chem Sci
; 7(8): 5260-5264, 2016 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30155175
16.
SHP2 phosphatase as a novel therapeutic target for melanoma treatment.
Oncotarget
; 7(45): 73817-73829, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27650545
17.
Palladium-Catalyzed Site-Selective Fluorination of Unactivated C(sp(3))-H Bonds.
Org Lett
; 17(15): 3738-41, 2015 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26205696
18.
Rhodium-catalyzed direct synthesis of unprotected NH-sulfoximines from sulfoxides.
Chem Commun (Camb)
; 50(68): 9687-9, 2014 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25016917
19.
Palladium-catalyzed chemoselective decarboxylative ortho acylation of benzoic acids with α-oxocarboxylic acids.
Org Lett
; 15(12): 2930-3, 2013 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23721458
20.
Margareta Mikkelsen.
Am J Med Genet A
; 120A(1): 144-54, 2003 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12794709